Barrett's esophagus: Pathologic considerations and implications for treatment

Seminars in Thoracic and Cardiovascular Surgery

Volumn 17, Issue 4, 2005, Pages 292-300

  Rice, Thomas W ^a   Mendelin, Joel E ^a   Goldblum, John R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Barrett's adenocarcinoma; Barrett's esophagus; High grade dysplasia; Intramucosal cancer

Indexed keywords

ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER PREVENTION; CLINICAL PROTOCOL; CLINICAL TRIAL; COLUMNAR EPITHELIUM; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS SURGERY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DYSPLASIA; GOBLET CELL; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; META ANALYSIS; REMISSION; SQUAMOUS EPITHELIUM; STOMACH FUNDOPLICATION; SYSTEMATIC REVIEW; TREATMENT INDICATION;

EID: 31144474845     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2005.10.002     Document Type: Article

References (38)

1. R.E. Sampliner Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology Am J Gastroenterol 93 7 1998 1028-1032
2. R.C. Haggitt Barrett's esophagus, dysplasia, and adenocarcinoma Hum Pathol 25 10 1994 982-993
3. R.C. Haggitt B.J. Reid P.S. Rabinovitch et al. Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk Am J Pathol 131 1 1988 53-61
4. D.S. Levine C.E. Rubin B.J. Reid et al. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study Lab Invest 60 3 1989 418-432
5. F.A. Offner K.J. Lewin W.M. Weinstein Metaplastic columnar cells in Barrett's esophagus: A common and neglected cell type Hum Pathol 27 9 1996 885-889
6. E. Rios-Castellanos F. Sitas N.A. Shepherd et al. Changing pattern of gastric cancer in Oxfordshire Gut 33 10 1992 1312-1317
7. J.C. Salvon-Harman B. Cady S. Nikulasson et al. Shifting proportions of gastric adenocarcinomas Arch Surg 129 4 1994 381-388
8. S.J. Spechler J.M. Zeroogian D.A. Antonioli et al. Prevalence of metaplasia at the gastro-oesophageal junction Lancet 344 8936 1994 1533-1536
9. M.H. Johnston A.S. Hammond W. Laskin et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy Am J Gastroenterol 91 8 1996 1507-1511
10. S. Nandurkar N.J. Talley C.J. Martin et al. Short segment Barrett's oesophagus prevalence, diagnosis and associations Gut 40 6 1997 710-715
11. N.J. Trudgill S.K. Suvarna K.C. Kapur et al. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy Gut 41 1997 585-589
12. W.K. Hirota T.M. Loughney D.J. Lazas et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction prevalence and clinical data Gastroenterology 116 2 1999 277-285
13. T.G. Morales R.E. Sampliner A. Bhattacharyya Intestinal metaplasia of the gastric cardia Am J Gastroenterol 92 3 1997 414-418
14. S. Oberg J.H. Peters T.R. DeMeester et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease Ann Surg 226 4 1997 522-530
15. A. Hackelsberger T. Gunther V. Schultze et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 43 1 1998 17-21
16. J.R. Goldblum J.J. Vicari G.W. Falk et al. Inflammation and intestinal metaplasia of the gastric cardia: The role of gastroesophageal reflux and H. pylori infection Gastroenterology 114 4 1998 633-639
17. A.H. Ormsby J.R. Goldblum T.W. Rice et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach Hum Pathol 30 3 1999 288-294
18. A.H. Ormsby M.F. Vaezi J.E. Richter et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus Gastroenterology 119 3 2000 683-690
19. A. Couvelard J.M. Cauvin D. Goldfain et al. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology Gut 49 6 2001 761-766
20. R.H. Riddell H. Goldman D.F. Ransohoff et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications Hum Pathol 14 11 1983 931-968
21. J.F. Sabik T.W. Rice J.R. Goldblum et al. Superficial esophageal carcinoma Ann Thorac Surg 60 4 1995 896-901
22. T.W. Rice E.H. Blackstone J.R. Goldblum et al. Superficial adenocarcinoma of the esophagus J Thorac Cardiovasc Surg 122 6 2001 1063-1076
23. J. Mendelin A.E. Bennett E. Castilla et al. Interobserver agreement in the evaluation of pre-resection biopsies with at least high grade dysplasia (HGD) in 163 Barrett's esophagus (BE) patients (abstract) Mod Pathol 18 2005 112A
24. B.J. Reid W.M. Weinstein K.J. Lewin et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions Gastroenterology 94 1 1988 81-90
25. G.W. Falk T.W. Rice J.R. Goldblum et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia Gastrointest Endosc 49 2 1999 170-176
26. B.J. Reid R.C. Haggitt C.E. Rubin et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus Hum Pathol 19 2 1988 166-178
27. E. Montgomery M.P. Bronner J.R. Goldblum et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation Hum Pathol 32 4 2001 368-378
28. R. Dekel D.E. Wakelin C. Wendel et al. Progression or regression of Barrett's esophagus - is it all in the eye of the beholder? Am J Gastroenterol 98 12 2003 2612-2615
29. F.T. Peters S. Ganesh E.J. Kuipers et al. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study Gut 45 4 1999 489-494
30. N.M. Guda S. Partington N. Vakil Inter- and intra-observer variability in the measurement of length at endoscopy: Implications for the measurement of Barrett's esophagus Gastrointest Endosc 59 6 2004 655-658
31. S. Haag S. Nandurkar N.J. Talley Regression of Barrett's esophagus: The role of acid suppression, surgery, and ablative methods Gastrointest Endosc 50 2 1999 229-240
32. D.L. Brand J.T. Ylvisaker M. Gelfand et al. Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery N Engl J Med 302 15 1980 844-848
33. R.R. Gurski J.H. Peters J.A. Hagen et al. Barrett's esophagus can and does regress after antireflux surgery: A study of prevalence and predictive features J Am Coll Surg 196 5 2003 706-712
34. J.M. O'Riordan P.J. Byrne N. Ravi et al. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery Am J Surg 188 1 2004 27-33
35. M. Skacel R.E. Petras T.L. Gramlich et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression Am J Gastroenterol 95 12 2000 3383-3387
36. K.E. Corey S.M. Schmitz N.J. Shaheen Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis Am J Gastroenterol 98 11 2003 2390-2394
37. T. Tran S.J. Spechler P. Richardson et al. Fundoplication and risk of esophageal cancer in gastroesophageal reflux disease A Veterans Affairs Cohort Study Am J Gastroenterol 100 5 2005 1002-1008
38. A. Csendes P. Burdiles I. Braghetto et al. Adenocarcinoma appearing very late after antireflux surgery for Barrett's esophagus: Long-term follow-up, review of the literature, and addition of six patients J Gastrointest Surg 8 4 2004 434-441